Platinum Chemo Improves TNBC Survival for Patients Younger Than 50
Elisa Becze, BA, ELS, Editor
Voice
Description
Adding carboplatin to standard neoadjuvant chemotherapy for patients with triple-negative breast cancer improves complete response, event-free survival, and overall survival, researchers reported in study findings presented in abstract GS5-01 during the 2022 San Antonio Breast Cancer Symposium.